On April 7, 2023, Genome & Company closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,560 KRW | -2.67% | -4.93% | -47.48% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,320 KRW | +3.44% | +10.39% | 3.08B | ||
6,560 KRW | -2.67% | -4.93% | 71.37M | ||
1st Jan change | Capi. | |
---|---|---|
-47.48% | 71.37M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A314130 Stock
- News Genome & Company
- Genome & Company announced that it has received KRW 23 billion in funding from a group of investors